Literature DB >> 30986542

False positive fourth generation HIV test in a patient with severe malaria.

Jessica M Stempel1, Andres L Mora Carpio2, Daniel Puga2, Sarah Perloff3.   

Abstract

Severe malaria is an uncommon diagnosis in the United States. However, awareness of signs, symptoms, and treatment options is imperative in order to promptly initiate optimal therapy. False positive human immunodeficiency virus (HIV) results are rare in the setting of acute malaria infection and with the introduction of newer fourth-generation immunoassays. The Centers for Disease Control algorithms assist in confirming true HIV infection (Branson et al. 2014).
Copyright © 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  False positive; Fourth generation immunoassay; Human immunodeficiency virus; Severe malaria

Mesh:

Year:  2019        PMID: 30986542     DOI: 10.1016/j.ijid.2019.04.007

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  3 in total

1.  False reactive HIV-1 diagnostic test results in an individual from Kenya on multiple testing platforms-A case report.

Authors:  Jew Ochola; Michelle Imbach; Leigh Anne Eller; Mark de Souza; Chiaka Nwoga; June Doryne Otieno; Lucas Otieno; Eric Rono; Edwin Kamau; Trevor A Crowell; John Kevin Owuoth; Christina S Polyak; Valentine Sing'oei
Journal:  IDCases       Date:  2020-12-25

2.  Comprehensive investigation of sources of misclassification errors in routine HIV testing in Zimbabwe.

Authors:  Simon Gregson; Louisa Moorhouse; Tawanda Dadirai; Haynes Sheppard; Justin Mayini; Nadine Beckmann; Morten Skovdal; Janet Dzangare; Brian Moyo; Rufurwokuda Maswera; Benjamin A Pinsky; Sungano Mharakurwa; Ian Francis; Owen Mugurungi; Constance Nyamukapa
Journal:  J Int AIDS Soc       Date:  2021-04       Impact factor: 5.396

3.  Repeated false reactive ADVIA centaur® and bio-rad Geenius™ HIV tests in a patient self-administering anabolic steroids.

Authors:  Polly Tsybina; Maurice Hennink; Tania Diener; Jessica Minion; Amanda Lang; Stephanie Lavoie; John Kim; Alexander Wong
Journal:  BMC Infect Dis       Date:  2020-01-06       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.